However, EREG overexpression in stromal cells failed to confer survival advantage when these cells per se were treated with increasing concentrations of genotoxic chemicals such as BLEO, implying different survival mechanisms between cancer and stromal cells (Supplementary Fig. 5i). The gene discussed is EREG; the disease is cancer.